
Company Info
Year Established2020
Contacts
Rodrigo Fernandez-Valdivia, Ph.D.Founder & President
Company Description
Alelopharma's AleloMAXTM innovative technology uses a proprietary chemistry design for unmatched ultra-specificity, unprecedented ultra-sensitivity and broad applicability in molecular probing, pathogen testing and biomarkers sensing. Unlike conventional molecular detection methods, AleloMAXTM uses an innovative synergistic probing system providing detection levels significantly superior to current on-market molecular diagnostic and monitoring systems.